Related references
Note: Only part of the references are listed.Donanemab in Early Alzheimer's Disease
Mark A. Mintun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Treatments for Alzheimer's disease emerge
Dennis J. Selkoe
SCIENCE (2021)
A beta oligomers trigger and accelerate A beta seeding
Natalie Katzmarski et al.
BRAIN PATHOLOGY (2020)
Dual-Sensitive Nanomicelles Enhancing Systemic Delivery of Therapeutically Active Antibodies Specifically into the Brain
Jinbing Xie et al.
ACS NANO (2020)
The coarse-grained plaque: a divergent Aβ plaque-type in early-onset Alzheimer's disease
Baayla D. C. Boon et al.
ACTA NEUROPATHOLOGICA (2020)
New Alzheimer's disease model mouse specialized for analyzing the function and toxicity of intraneuronal Amyloid β oligomers
Tomoyo Ochiishi et al.
SCIENTIFIC REPORTS (2019)
Removal of p75 Neurotrophin Receptor Expression from Cholinergic Basal Forebrain Neurons Reduces Amyloid-β Plaque Deposition and Cognitive Impairment in Aged APP/PS1 Mice
Lei Qian et al.
MOLECULAR NEUROBIOLOGY (2019)
A critical appraisal of amyloid-βtargeting therapies for Alzheimer disease
Francesco Panza et al.
NATURE REVIEWS NEUROLOGY (2019)
Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β
Joseph W. Arndt et al.
SCIENTIFIC REPORTS (2018)
Inhibition of β-Amyloid Channels with a Drug Candidate wgx-50 Revealed by Molecular Dynamics Simulations
Shuang Hou et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain
Y. Anraku et al.
NATURE COMMUNICATIONS (2017)
Intracellular Delivery of Charge-Converted Monoclonal Antibodies by Combinatorial Design of Block/Homo Polyion Complex Micelles
Ahram Kim et al.
BIOMACROMOLECULES (2016)
Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges
Holger Cynis et al.
MOLECULAR NEURODEGENERATION (2016)
Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials
Rik Vandenberghe et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Monoclonal antibody with conformational specificity for a toxic conformer of amyloid β42 and its application toward the Alzheimer's disease diagnosis
Kazuma Murakami et al.
SCIENTIFIC REPORTS (2016)
Destabilization of Alzheimer's Aβ42 Protofibrils with a Novel Drug Candidate wgx-50 by Molecular Dynamics Simulations
Huai-Meng Fan et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2015)
Forebrain microglia from wild-type but not adult 5xFAD mice prevent amyloid-β plaque formation in organotypic hippocampal slice cultures
Sabine Hellwig et al.
SCIENTIFIC REPORTS (2015)
A Novel Drug Candidate for Alzheimer's Disease Treatment: gx-50 Derived from Zanthoxylum Bungeanum
Maoping Tang et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Disease Modifying Therapies for Alzheimer's Disease Targeting Aβ Oligomers: Implications for Therapeutic Mechanisms
Etsuro Matsubara et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Sortilin is required for toxic action of Aβ oligomers (AβOs): Extracellular AβOs trigger apoptosis, and intraneuronal AβOs impair degradation pathways
Ayumi Takamura et al.
LIFE SCIENCES (2012)
A Plaque-Specific Antibody Clears Existing β-amyloid Plaques in Alzheimer's Disease Mice
Ronald B. DeMattos et al.
NEURON (2012)
A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo
Takami Tomiyama et al.
JOURNAL OF NEUROSCIENCE (2010)
Structure and function of the blood-brain barrier
N. Joan Abbott et al.
NEUROBIOLOGY OF DISEASE (2010)
Charge-Conversional Polyionic Complex Micelles-Efficient Nanocarriers for Protein Delivery into Cytoplasm
Yan Lee et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
A new amyloid μ variant favoring oligomerization in Alzheimer's-type dementia
Takami Tomiyama et al.
ANNALS OF NEUROLOGY (2008)
Amyloidogenic processing of amyloid precursor protein:: Evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-β
Holger Cynis et al.
BIOCHEMISTRY (2008)
Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease-like pathology
Stephan Schilling et al.
NATURE MEDICINE (2008)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons
Makiko Nagai et al.
NATURE NEUROSCIENCE (2007)
On the seeding and oligomerization of pGlu-amyloid peptides (in vitro)
Stephan Schilling et al.
BIOCHEMISTRY (2006)
Metabolism of amyloid-β peptide and Alzheimer's disease
N Iwata et al.
PHARMACOLOGY & THERAPEUTICS (2005)
Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression
K Miyata et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Alzheimer's disease is a synaptic failure
DJ Selkoe
SCIENCE (2002)
Share Paper
